HYPERINSULINEMIA AS A COMORBID CONDITION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Main Article Content
Abstract:
Hyperinsulinemia is a condition characterized by elevated blood insulin levels, which is often found in patients with chronic obstructive pulmonary disease (COPD). Comorbid conditions worsen the course of COPD, increasing the risk of cardiovascular complications and metabolic disorders. This study aimed to evaluate the frequency of hyperinsulinemia in patients with COPD, its impact on disease severity, inflammation, and lung function. Data analysis reveals a link between metabolic disorders and the severity of respiratory disease, and highlights the need for a comprehensive approach to treating these patients.
Article Details
How to Cite:
References:
Barnes, P.J. (2016). Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Medicine, 13(3), e1002090. https://doi.org/10.1371/journal.pmed.1002090
Watz, H., Waschki, B., Boehme, C., et al. (2009). Systemic inflammation in patients with chronic obstructive pulmonary disease: relationship to insulin resistance. Thorax, 64(7), 611–616. https://doi.org/10.1136/thx.2008.108028
Celli, B.R., & Wedzicha, J.A. (2019). Update on clinical aspects of chronic obstructive pulmonary disease. New England Journal of Medicine, 381, 1257–1266. https://doi.org/10.1056/NEJMra1900500
Fabbri, L.M., & Rabe, K.F. (2007). From COPD to chronic systemic inflammatory syndrome? Lancet, 370(9589), 797–799. https://doi.org/10.1016/S0140-6736(07)61374-3
MacNee, W. (2013). Systemic inflammation and comorbidities in COPD: a result of “overspill” of inflammatory mediators from the lungs? European Respiratory Journal, 22(4), 819–828. https://doi.org/10.1183/09031936.03.00089003